Metoprolol Pharmaclan

Metoprolol, the active ingredient in Metoprolol Pharmaclan, is a beta blocker presented as a oral tablet for oral use. It treats hypertension, angina pectoris, myocardial infarction, heart failure and cardiac arrhythmias in adult patients.

GNH USA supplies Metoprolol Pharmaclan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoprolol is a selective β1‑adrenergic antagonist used in several cardiovascular conditions. - Hypertension: lowers blood pressure by reducing heart rate and cardiac output. - Angina pectoris: decreases myocardial oxygen demand, relieving chest pain. - Myocardial infarction: improves survival after an acute heart attack by limiting workload. - Heart failure: reduces ventricular remodeling and improves functional capacity. - Cardiac arrhythmias: controls abnormal heart rhythms such as atrial fibrillation.

Metoprolol may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Fatigue or tiredness - Dizziness or light‑headedness - Cold extremities - Gastrointestinal upset (nausea, abdominal discomfort) - Bradycardia (slow heart rate) - Sleep disturbances or vivid dreams

Serious or Rare Side Effects: - Severe bradycardia or heart block - Acute heart failure exacerbation - Bronchospasm in susceptible individuals - Hypotension leading to syncope - Allergic reactions (rash, angioedema) - Depression or mood changes

Before initiating Metoprolol, consider the following safety measures. - Cardiovascular assessment: evaluate heart rate, blood pressure, and cardiac function. - Respiratory status: avoid in patients with uncontrolled asthma or severe COPD. - Diabetes monitoring: may mask hypoglycaemia symptoms; adjust glucose checks. - Concomitant drugs: review for interactions that affect heart rate or blood pressure. - Pregnancy and lactation: use only if benefits outweigh potential risks. - Store at ambient temperature: keep below 25 °C, retain in original container, protect from moisture and direct sunlight.

Metoprolol can interact with several medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Non‑selective beta‑blockers: additive bradycardia. - Calcium channel blockers (verapamil, diltiazem): profound heart‑rate depression. - Antihypertensives (ACE inhibitors, ARBs): risk of excessive hypotension. - Clonidine abrupt withdrawal: severe hypertension rebound. - Antidiabetic agents: may conceal hypoglycaemia signs.

Moderate Interactions (Monitor Closely): - NSAIDs: may reduce antihypertensive effect. - Antidepressants (SSRIs, SNRIs): potential for increased bradycardia. - Digoxin: enhanced cardiac conduction effects. - CYP2D6 inhibitors (e.g., fluoxetine, quinidine): increase Metoprolol plasma levels. - Potassium‑sparing diuretics: monitor electrolytes and blood pressure.